// App-Quantinova.ai

THU0688 (2018) : Do certain dmards increase risk of new-onset type 2 diabetes? evaluation of patients’ baseline characteristics

Researchers

Presenter

  • E. Alemao

Principal Investigators

  • Z. Guo

  • L. Ferri

  • L. Burns

Medical Centers

  • Bristol-Myers Sqiubb, Princeton, NJ

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Type 2 diabetes mellitus

Biomarkers

  • Tumor necrosis factor

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved